Literature DB >> 3720777

Ventricular arrhythmias during acute myocardial ischaemia in man. The role and significance of R-ST-T alternans and the prevention of ischaemic sudden death by medical treatment.

J A Salerno, M Previtali, C Panciroli, C Klersy, M Chimienti, M Regazzi Bonora, E Marangoni, C Falcone, L Guasti, C Campana.   

Abstract

Malignant ventricular arrhythmias appearing during acute myocardial ischaemia, are the most frequent mechanism of sudden death. ST-T alternans is the result of an intraischaemic conduction delay and is frequently associated with those potentially lethal arrhythmias. In fact, such a phenomenon was seen in 35% of 46/86 patients with Prinzmetal's variant angina who showed ventricular arrhythmias during ischaemia, while it was never observed in the remaining 40 patients without arrhythmias during ischaemia. Therefore ST-segment alternans should be considered a reliable marker of the possible occurrence of ventricular arrhythmias during myocardial ischaemia. ST-T-segment alternans is associated with R alternans, as clearly demonstrated by thoracic maps, and this phenomenon is due to a 2:1 intraischaemic block. The patients with Prinzmetal's variant angina who present ventricular arrhythmias during ischaemia, show a more prominent increase of the positive area of the QRS (411.75 +/- 102.5 vs 294.05 +/- 80.3 mu volts ms), that is, a more relevant intraischaemic conduction delay. The effects of different pretreatments (lidocaine, propranolol and diltiazem) on arrhythmias related to vasospastic myocardial ischaemia induced by ergonovine maleate, were evaluated in four patients with Prinzmetal's variant angina. As in experimental observations, neither a 'pure' antiarrhythmic agent like lidocaine, nor a betablocking agent like propranolol, prevented acute ischaemic ventricular arrhythmias. Only the calcium antagonist, diltiazem, seemed to prevent such arrhythmias. However, these findings necessitate further confirmation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3720777

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

1.  Comparison of standard versus orthogonal ECG leads for T-wave alternans identification.

Authors:  Laura Burattini; Sumche Man; Roberto Burattini; Cees A Swenne
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-04       Impact factor: 1.468

2.  Toward prediction of the local onset of alternans in the heart.

Authors:  Alexander R Cram; Hrishikesh M Rao; Elena G Tolkacheva
Journal:  Biophys J       Date:  2011-02-16       Impact factor: 4.033

Review 3.  Prinzmetal angina: ECG changes and clinical considerations: a consensus paper.

Authors:  Antonio Bayés de Luna; Iwona Cygankiewicz; Adrian Baranchuk; Miquel Fiol; Yochai Birnbaum; Kjell Nikus; Diego Goldwasser; Javier Garcia-Niebla; Samuel Sclarovsky; Hein Wellens; Günter Breithardt
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-09       Impact factor: 1.468

4.  A novel lead configuration for optimal spatio-temporal detection of intracardiac repolarization alternans.

Authors:  Eric H Weiss; Faisal M Merchant; Andre d'Avila; Lori Foley; Vivek Y Reddy; Jagmeet P Singh; Theofanie Mela; Jeremy N Ruskin; Antonis A Armoundas
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-03-23

Review 5.  Noninvasive sudden death risk stratification by ambulatory ECG-based T-wave alternans analysis: evidence and methodological guidelines.

Authors:  Richard L Verrier; Bruce D Nearing; Kevin F Kwaku
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-01       Impact factor: 1.468

Review 6.  Ventricular repolarization measures for arrhythmic risk stratification.

Authors:  Francesco Monitillo; Marta Leone; Caterina Rizzo; Andrea Passantino; Massimo Iacoviello
Journal:  World J Cardiol       Date:  2016-01-26

7.  Cardiac electrophysiological adaptations in the equine athlete-Restitution analysis of electrocardiographic features.

Authors:  Mengye Li; Karan R Chadda; Gareth D K Matthews; Celia M Marr; Christopher L-H Huang; Kamalan Jeevaratnam
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.